skip to content

Data-Driven Drug Discovery and Molecular Informatics

Tips on using this search form

  • All search terms are case-insensitive
  • If you specify more than one search option (e.g. you search for both "Authors" and "Paper title") then the publications returned will be those that match all of your search terms
  • To reset the search form, click here
  • Currently displaying 121 - 140 of 573 publications
Prediction of inotropic effect based on calcium transients in human iPSC-derived cardiomyocytes using novel waveform parameters and a modified random forest algorithm
H Yang, O Obrezanova, A Pointon, W Stebbeds, J Francis, KA Beattie, P Clements, JS Harvey, GF Smith, A Bender
– TOXICOLOGY LETTERS
(2021)
350,
S61
Opsins and gonadal circadian rhythm in the swordfish (Xiphias gladius) ovary: Their potential roles in puberty and reproductive seasonality
D Basili, G Gioacchini, V Todisco, M Candelma, L Marisaldi, L Pappalardo, O Carnevali
– General and comparative endocrinology
(2020)
303,
113707
De novo transcriptome assembly, functional annotation and characterization of the Atlantic bluefin tuna (Thunnus thynnus) larval stage
L Marisaldi, D Basili, G Gioacchini, A Canapa, O Carnevali
– Marine genomics
(2020)
58,
100834
Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports.
IA Smit, AM Afzal, CHG Allen, F Svensson, T Hanser, A Bender
– Chem Res Toxicol
(2020)
34,
365
New Associations Between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets
KA Giblin, D Basili, AM Afzal, L Rosenbrier-Ribeiro, N Greene, I Barrett, SJ Hughes, A Bender
– Chemical research in toxicology
(2020)
34,
438
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet.
A Bender, I Cortés-Ciriano
– Drug Discov Today
(2020)
26,
511
5‑Phenyl-1,3,4-oxadiazol-2(3H)‑ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit
W Mahy, NJ Willis, Y Zhao, HL Woodward, F Svensson, J Sipthorp, L Vecchia, RR Ruza, J Hillier, S Kjær, S Frew, A Monaghan, M Bictash, PC Salinas, P Whiting, J-P Vincent, EY Jones, PV Fish
– Journal of medicinal chemistry
(2020)
63,
12942
Network integration and modelling of dynamic drug responses at multi-omics levels
N Selevsek, F Caiment, R Nudischer, H Gmuender, I Agarkova, FL Atkinson, I Bachmann, V Baier, G Barel, C Bauer, S Boerno, N Bosc, O Clayton, H Cordes, S Deeb, S Gotta, P Guye, A Hersey, FMI Hunter, L Kunz, A Lewalle, M Lienhard, J Merken, J Minguet, B Oliveira, C Pluess, U Sarkans, Y Schrooders, J Schuchhardt, I Smit, C Thiel, B Timmermann, M Verheijen, T Wittenberger, W Wolski, A Zerck, S Heymans, L Kuepfer, A Roth, R Schlapbach, S Niederer, R Herwig, J Kleinjans
– Communications Biology
(2020)
3,
573
Comparison of Scaling Methods to Obtain Calibrated Probabilities of Activity for Protein-Ligand Predictions
LH Mervin, AM Afzal, O Engkvist, A Bender
– Journal of chemical information and modeling
(2020)
60,
4546
Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells
L-L Pruteanu, L Kopanitsa, D Módos, E Kletnieks, E Samarova, A Bender, LD Gomez, DS Bailey
– PLoS One
(2020)
15,
e0239551
Identification of SARS-CoV-2 induced pathways reveal drug repurposing strategies
N Han, W Hwang, K Tzelepis, P Schmerer, E Yankova, M MacMahon, W Lei, N Katritsis, A Liu, A Schuldt, R Harris, K Chapman, F McCaughan, F Weber, T Kouzarides
(2020)
Screening of a Custom-Designed Acid Fragment Library Identifies 1‑Phenylpyrroles and 1‑Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity
W Mahy, M Patel, D Steadman, HL Woodward, BN Atkinson, F Svensson, NJ Willis, A Flint, D Papatheodorou, Y Zhao, L Vecchia, RR Ruza, J Hillier, S Frew, A Monaghan, A Costa, M Bictash, MW Walter, EY Jones, PV Fish
– Journal of medicinal chemistry
(2020)
63,
9464
Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
GHS Dreiman, M Bictash, PV Fish, L Griffin, F Svensson
– SLAS Discovery
(2020)
26,
257
Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel.
MJ Burton, J Cresser-Brown, M Thomas, N Portolano, J Basran, SL Freeman, H Kwon, AR Bottrill, MJ Llansola-Portoles, AA Pascal, R Jukes-Jones, T Chernova, R Schmid, NW Davies, NM Storey, P Dorlet, PCE Moody, JS Mitcheson, EL Raven
– J Biol Chem
(2020)
295,
13277
Insights into the synergistic mechanism of target resistance: A case study of N. lugens RDL-GABA receptors and fipronil.
T Li, C Zhou, N Zheng, H Yang, G Kuang, X Shao, Z Li, J Cheng
– Biophys Chem
(2020)
265,
106426
Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens.
I Ayestaran, A Galhoz, E Spiegel, B Sidders, JR Dry, F Dondelinger, A Bender, U McDermott, F Iorio, MP Menden
– Patterns (N Y)
(2020)
1,
100065
Associating adverse drug effects with protein targets by integrating adverse event, in vitro bioactivity, and pharmacokinetic data
I Smit
(2020)
Neural Network Activation Similarity: A New Measure to Assist Decision Making in Chemical Toxicology
TEH Allen, AJ Wedlake, E Gelžinytė, C Gong, JM Goodman, S Gutsell, PJ Russell
– Chemical science
(2020)
11,
7335
Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports
I Smit, A Afzal, C Allen, F Svensson, T Hanser, A Bender
(2020)
2020.06.12.135939
QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction.
I Cortés-Ciriano, C Škuta, A Bender, D Svozil
– Journal of cheminformatics
(2020)
12,
41